Exelsus

San Miguel de Tucumán 4000

1 studies enrolling now · 2 studies all time

What they study most

Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Melanoma, Monoclonal Antibody

Studies at this site

• A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer — Recruiting now
• Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma — Running, not enrolling